Page last updated: 2024-10-28

hydroxyzine and Wolff-Parkinson-White Syndrome

hydroxyzine has been researched along with Wolff-Parkinson-White Syndrome in 1 studies

Hydroxyzine: A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
hydroxyzine : A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively.

Wolff-Parkinson-White Syndrome: A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumazawa, T1
Yasuda, K1
Amau, T1
Ikezono, E1

Other Studies

1 other study available for hydroxyzine and Wolff-Parkinson-White Syndrome

ArticleYear
[WPW syndrome and general anesthesia].
    Masui. The Japanese journal of anesthesiology, 1970, Volume: 19, Issue:1

    Topics: Anesthesia, General; Atropine; Child; Child, Preschool; Electrocardiography; Humans; Hydroxyzine; Ma

1970